Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.
Heleen A. Bardelmeijer(Slotervaartziekenhuis), Olaf van Tellingen(Dutch Cancer Society), Jos H. Beijnen(The Netherlands Cancer Institute), J.H.M. Schellens, W J Nooijen, Hilde Rosing(The Netherlands Cancer Institute), Kenneth R. Brouwer
PubMed
November 1, 2000
Cited by 121
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884